Close Menu

NEW YORK – Autoimmune disease diagnostics firm Exagen went public today at $14 per share.

In a statement on Wednesday, the Vista, California-based company said it is offering 3.6 million shares of its common stock and expects gross proceeds of $50.4 million from the initial public offering.

Its stock is listed on the Nasdaq under ticker symbol "XGN." In mid-morning trading, no shares had been traded.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.